Display Settings:

Format

Send to:

Choose Destination
    J Palliat Med. 2004 Jun;7(3):462-8.

    Opioid dose titration for severe cancer pain: a systematic evidence-based review.

    Source

    The Harry R. Horvitz Center for Palliative Medicine, Cleveland, Ohio, USA. davism6@ccf.org

    Abstract

    Dosing strategies to achieve rapid analgesia in patients with severe or crescendo cancer pain are important. A systematic review of research trials for treatment of severe or crescendo cancer pain was conducted; nine studies were identified. Eight trials were prospective; two were randomized between different dosing strategies. Dosing frequency predicted onset to analgesia regardless of baseline opioid dose. None of the trials were associated with evidence of respiratory depression. The studies all suffered significant methodological problems limiting broad conclusions. Until better data exist, opioid dose titration for severe/crescendo pain will be guided by expert opinion and experience.

    PMID:
    15265356
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Mary Ann Liebert, Inc.

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk